Allergy Therapeutics (AGY)

 

Latest News

Broker Forecast - Stifel issues a broker note on Allergy Therapeutics PLC

Stifel today reaffirms its buy investment rating on Allergy Therapeutics PLC (LON:AGY) and set its price target at 60p.

Allergy Therapeutics vaccine gains CTA spproval

Allergy Therapeutics has received approval for a clinical study of its novel house dust mite allergy vaccine. The company s...

House Dust Mite Allergy Vaccine Gains CTA Approval

RNS Number: 7777W Allergy Therapeutics PLC 14 February 2017 Al l e r g y Th e r a p e u ti cs p l c (" A l l e r gy T he r a peu t i cs" or t he " C o m p a n y " ) Novel House Dust Mite Allergy Vaccine Gains Clinical Trial Application Approval CTA approval in Spain for Phase I AM101 clinical study evaluating safety of adjuvanted, modified house dust mite allergy v...

Directorate Change

RNS Number: 2838W Allergy Therapeutics PLC 08 February 2017 8 February 2 0 17 A l l e r g y Th e r a p e u ti cs p l c (" A l l e r gy T he r a peu t i cs" or t he ' C o m p a n y " ) Directorate Change Allergy Therapeutics (AIM:AGY), the fully integrated specialty pharmaceutical company specialising in allergy vaccines, announces the appointment of Mr Jeff Barton t...

All News

DateHeadlineSource
14-02-17Broker Forecast - Stifel issues a broker note on Allergy Therapeutics PLCStockMarketWire
14-02-17Allergy Therapeutics vaccine gains CTA spprovalStockMarketWire
14-02-17House Dust Mite Allergy Vaccine Gains CTA ApprovalRNS
08-02-17Directorate ChangeRNS
01-02-17Allergy Therapeutics positive data in peanut allergy vaccineStockMarketWire
01-02-17Positive Efficacy & Safety Data in Peanut VaccineRNS
20-01-17Hardman Research: Investment driving market shareRNS
19-01-17Broker Forecast - finnCap issues a broker note on Allergy Therapeutics PLCStockMarketWire
19-01-17Allergy Therapeutics revenues up StockMarketWire
19-01-17Trading UpdateRNS
09-01-17Top 10 small-cap share tips for 2017Interactive Investor
06-01-17Broker Forecast - finnCap issues a broker note on Allergy Therapeutics PLCStockMarketWire
30-12-16Grant of AwardsRNS
25-11-16Allergy Therapeutics resolutions passed at AGMStockMarketWire
24-11-16Result of AGMRNS
02-11-16Allergy Therapeutics granted EU patent StockMarketWire
02-11-16EU Patent Office grants patent for MCTRNS
27-10-16Issue of equity in respect of exercise of optionsRNS
24-10-16Annual Report and AccountsRNS
14-10-16Share of the week: Tipped to double againInteractive Investor
10-10-16New data from novel adjuvant systemRNS
03-10-16Issue of equity in respect of exercise of optionsRNS
29-09-16Director Deals - Allergy Therapeutics PLC (AGY)StockMarketWire
29-09-16Director/PDMR ShareholdingRNS
28-09-16Director Deals - Allergy Therapeutics PLC (AGY)StockMarketWire
28-09-16Director/PDMR ShareholdingRNS
26-09-16Allergy Therapeutics tipped to bounce backInteractive Investor
26-09-16Director Deals - Allergy Therapeutics PLC (AGY)StockMarketWire
26-09-16Director/PDMR ShareholdingRNS
26-09-16Hardman Research: Performance drives market shareRNS
26-09-16Allergy Therapeutics revenues up StockMarketWire
26-09-16Allergy Therapeutics revenues up StockMarketWire
26-09-16Allergy Therapeutics Preliminary ResultsRNS
21-09-16Broker Forecast - Numis issues a broker note on Allergy Therapeutics PLCStockMarketWire
21-09-16Allergy Therapeutics options exercised StockMarketWire
20-09-16Issue of equity in respect of exercise of optionsRNS
05-09-16Allergy Therapeutics schedules FY results StockMarketWire
05-09-16Notice of Preliminary ResultsRNS
31-08-16Allergy Therapeutics Plc to present at the Shares Investor Evening in London on 27th September 2016StockMarketWire
13-07-16Trading UpdateRNS

RSS feeds

  • Editorial news feed for LSE:AGY Editorial
  • Regulatory news feed for LSE:AGY Regulatory